EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis
- PMID:19930447
- DOI: 10.1111/j.1468-1331.2009.02862.x
EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis
Abstract
Background: Lyme neuroborreliosis (LNB) is a nervous system infection caused by Borrelia burgdorferi sensu lato (Bb).
Objectives: To present evidence-based recommendations for diagnosis and treatment.
Methods: Data were analysed according to levels of evidence as suggested by EFNS.
Recommendations: The following three criteria should be fulfilled for definite LNB, and two of them for possible LNB: (i) neurological symptoms; (ii) cerebrospinal fluid (CSF) pleocytosis; (iii) Bb-specific antibodies produced intrathecally. PCR and CSF culture may be corroborative if symptom duration is <6 weeks, when Bb antibodies may be absent. PCR is otherwise not recommended. There is also not enough evidence to recommend the following tests for diagnostic purposes: microscope-based assays, chemokine CXCL13, antigen detection, immune complexes, lymphocyte transformation test, cyst formation, lymphocyte markers. Adult patients with definite or possible acute LNB (symptom duration <6 months) should be offered a single 14-day course of antibiotic treatment. Oral doxycycline (200 mg daily) and intravenous (IV) ceftriaxone (2 g daily) are equally effective in patients with symptoms confined to the peripheral nervous system, including meningitis (level A). Patients with CNS manifestations should be treated with IV ceftriaxone (2 g daily) for 14 days and late LNB (symptom duration >6 months) for 3 weeks (good practice points). Children should be treated as adults, except that doxycycline is contraindicated under 8 years of age (nine in some countries). If symptoms persist for more than 6 months after standard treatment, the condition is often termed post-Lyme disease syndrome (PLDS). Antibiotic therapy has no impact on PLDS (level A).
Similar articles
- Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children.Sillanpää H, Skogman BH, Sarvas H, Seppälä IJ, Lahdenne P.Sillanpää H, et al.Scand J Infect Dis. 2013 Jul;45(7):526-30. doi: 10.3109/00365548.2013.776700. Epub 2013 Mar 22.Scand J Infect Dis. 2013.PMID:23521134
- Clinical manifestations and long-term outcome of early Lyme neuroborreliosis according to the European Federation of Neurological Societies diagnostic criteria (definite versus possible) in central Europe. A retrospective cohort study.Stupica D, Bajrović FF, Blagus R, Cerar Kišek T, Collinet-Adler S, Lah A, Levstek E, Ružić-Sabljić E.Stupica D, et al.Eur J Neurol. 2021 Sep;28(9):3155-3166. doi: 10.1111/ene.14962. Epub 2021 Jul 1.Eur J Neurol. 2021.PMID:34114701
- CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.Ljøstad U, Mygland A.Ljøstad U, et al.J Neurol. 2008 May;255(5):732-7. doi: 10.1007/s00415-008-0785-y. Epub 2008 Mar 17.J Neurol. 2008.PMID:18344056
- [Neuroborreliosis - Diagnostics, treatment and course].Dersch R, Rauer S.Dersch R, et al.Nervenarzt. 2017 Apr;88(4):419-431. doi: 10.1007/s00115-016-0263-1.Nervenarzt. 2017.PMID:28175945Review.German.
- Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients.Pfister HW, Rupprecht TA.Pfister HW, et al.Int J Med Microbiol. 2006 May;296 Suppl 40:11-6. doi: 10.1016/j.ijmm.2005.12.003. Epub 2006 Mar 9.Int J Med Microbiol. 2006.PMID:16524775Review.
Cited by
- A reappraisal of the u.s. Clinical trials of post-treatment lyme disease syndrome.Fallon BA, Petkova E, Keilp JG, Britton CB.Fallon BA, et al.Open Neurol J. 2012;6:79-87. doi: 10.2174/1874205X01206010079. Epub 2012 Oct 5.Open Neurol J. 2012.PMID:23091568Free PMC article.
- Lyme neuroborreliosis as a cause of sudden sensorineural hearing loss and facial palsy.Nitro L, Martino B, Fuccillo E, Felisati G, Saibene AM.Nitro L, et al.Clin Case Rep. 2022 Oct 11;10(10):e6412. doi: 10.1002/ccr3.6412. eCollection 2022 Oct.Clin Case Rep. 2022.PMID:36245466Free PMC article.
- Diagnostic criteria for pediatric multiple sclerosis.Rubin JP, Kuntz NL.Rubin JP, et al.Curr Neurol Neurosci Rep. 2013 Jun;13(6):354. doi: 10.1007/s11910-013-0354-3.Curr Neurol Neurosci Rep. 2013.PMID:23591756
- Serological Diagnostics of Lyme Borreliosis: Comparison of Universal and Borrelia Species-Specific Tests Based on Whole-Cell and Recombinant Antigens.Kodym P, Kurzová Z, Berenová D, Pícha D, Smíšková D, Moravcová L, Malý M.Kodym P, et al.J Clin Microbiol. 2018 Oct 25;56(11):e00601-18. doi: 10.1128/JCM.00601-18. Print 2018 Nov.J Clin Microbiol. 2018.PMID:30185509Free PMC article.
- [Papilledema and thought disorder].Waibel S, Pillunat LE, Matthé E.Waibel S, et al.Ophthalmologe. 2019 Oct;116(10):978-981. doi: 10.1007/s00347-018-0845-3.Ophthalmologe. 2019.PMID:30627763German.No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical